281 related articles for article (PubMed ID: 34983554)
1. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma.
Yu Z; Guo J; Liu Y; Wang M; Liu Z; Gao Y; Huang L
J Nanobiotechnology; 2022 Jan; 20(1):9. PubMed ID: 34983554
[TBL] [Abstract][Full Text] [Related]
2. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma.
Li H
Dig Liver Dis; 2022 May; 54(5):598-613. PubMed ID: 34344577
[TBL] [Abstract][Full Text] [Related]
3. Delta-like ligand 4/DLL4 regulates the capillarization of liver sinusoidal endothelial cell and liver fibrogenesis.
Chen L; Gu T; Li B; Li F; Ma Z; Zhang Q; Cai X; Lu L
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1663-1675. PubMed ID: 31233801
[TBL] [Abstract][Full Text] [Related]
4. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling.
Winkler M; Staniczek T; Kürschner SW; Schmid CD; Schönhaber H; Cordero J; Kessler L; Mathes A; Sticht C; Neßling M; Uvarovskii A; Anders S; Zhang XJ; von Figura G; Hartmann D; Mogler C; Dobreva G; Schledzewski K; Géraud C; Koch PS; Goerdt S
J Hepatol; 2021 Feb; 74(2):380-393. PubMed ID: 32916216
[TBL] [Abstract][Full Text] [Related]
5. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats.
Xie G; Wang X; Wang L; Wang L; Atkinson RD; Kanel GC; Gaarde WA; Deleve LD
Gastroenterology; 2012 Apr; 142(4):918-927.e6. PubMed ID: 22178212
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
Ruan Q; Wang H; Burke LJ; Bridle KR; Li X; Zhao CX; Crawford DHG; Roberts MS; Liang X
Int J Cancer; 2020 Sep; 147(6):1519-1527. PubMed ID: 32010970
[TBL] [Abstract][Full Text] [Related]
7. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
9. [Dynamic observation on capillarization of liver sinusoidal endothelial cells induced by
Zhang R; Xie J; Wei F; Mo X; Song P; Cai Y; Lu Y; Sun J; Zhou Y; Lin L; Zhang T; Chen M
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Apr; 36(1):34-43. PubMed ID: 38604683
[TBL] [Abstract][Full Text] [Related]
10. Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1.
Lin N; Meng L; Lin J; Chen S; Zhang P; Chen Q; Lin Y
J Cell Biochem; 2020 Feb; 121(2):1441-1451. PubMed ID: 31609020
[TBL] [Abstract][Full Text] [Related]
11. Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis.
Guo Q; Furuta K; Islam S; Caporarello N; Kostallari E; Dielis K; Tschumperlin DJ; Hirsova P; Ibrahim SH
Front Immunol; 2022; 13():983255. PubMed ID: 36091042
[TBL] [Abstract][Full Text] [Related]
12. The role of liver sinusoidal endothelial cells in cancer liver metastasis.
Yang M; Zhang C
Am J Cancer Res; 2021; 11(5):1845-1860. PubMed ID: 34094657
[TBL] [Abstract][Full Text] [Related]
13. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
[TBL] [Abstract][Full Text] [Related]
14. Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy.
Zhang LF; Wang XH; Zhang CL; Lee J; Duan BW; Xing L; Li L; Oh YK; Jiang HL
ACS Nano; 2022 Sep; 16(9):14029-14042. PubMed ID: 36036898
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.
Ji J; Eggert T; Budhu A; Forgues M; Takai A; Dang H; Ye Q; Lee JS; Kim JH; Greten TF; Wang XW
Hepatology; 2015 Aug; 62(2):481-95. PubMed ID: 25833323
[TBL] [Abstract][Full Text] [Related]
16. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
17. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
[TBL] [Abstract][Full Text] [Related]
18. Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis.
He S; Luo Y; Ma W; Wang X; Yan C; Hao W; Fang Y; Su H; Lai B; Liu J; Xiong Y; Bai T; Ren X; Liu E; Han H; Wu Y; Yuan Z; Wang Y
J Hepatol; 2024 Mar; ():. PubMed ID: 38460791
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
[TBL] [Abstract][Full Text] [Related]
20. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
